2019 Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin. Group Acute Leukemia Working Party (ALWP) 1st listed author Baron F Journal Haematologica.
2019 The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Shouval R Journal Blood.
2019 Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Battipaglia G Journal Blood.
2019 Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. Group Acute Leukemia Working Party (ALWP) Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Shouval R Journal Lancet Haematol.
2019 Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. Group Acute Leukemia Working Party (ALWP) 1st listed author Nagler A Journal Blood Adv.
2019 Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemia. Group Acute Leukemia Working Party (ALWP) 1st listed author Shouval R Journal Cancer.
2019 Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia. Group Acute Leukemia Working Party (ALWP) 1st listed author Canaani J Journal Leukemia.
2019 Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Ofran Y Journal Br J Haematol.
2019 Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Group Acute Leukemia Working Party (ALWP) 1st listed author Passweg JR Journal Biol Blood Marrow Transplant.
2019 Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Shimoni A Journal Blood Cancer J.
2019 Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Heinicke T Journal Bone Marrow Transplant.
2019 Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Pavlů J Journal J Hematol Oncol.